AVTX Insider Trading

Insider Ownership Percentage: 0.20%
Insider Buying (Last 12 Months): $7,948.80
Insider Selling (Last 12 Months): $1,675,108.80

Avalo Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Avalo Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Avalo Therapeutics Share Price & Price History

Current Price: $10.56
Price Change: Price Decrease of -0.37 (-3.39%)
As of 06/17/2024 01:51 PM ET

This chart shows the closing price history over time for AVTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Avalo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/26/2023Armistice Capital, LlcMajor ShareholderSell11,442$146.40$1,675,108.806,953View SEC Filing Icon  
6/20/2023Caissa Capital Management Ltd.Major ShareholderBuy8$993.60$7,948.805,940View SEC Filing Icon  
6/16/2023Caissa Capital Management Ltd.Major ShareholderBuy12$936.00$11,232.005,932View SEC Filing Icon  
6/14/2023Caissa Capital Management Ltd.Major ShareholderBuy25$835.20$20,880.005,906View SEC Filing Icon  
6/12/2023Caissa Capital Management Ltd.Major ShareholderBuy8$1,041.60$8,332.805,844View SEC Filing Icon  
6/9/2023Christopher Ryan SullivanCFOBuy2$820.80$1,641.605View SEC Filing Icon  
6/9/2023Garry Arthur NeilCEOBuy16$820.80$13,132.8055View SEC Filing Icon  
5/30/2023Caissa Capital Management Ltd.Major ShareholderBuy2$688.80$1,377.605,772View SEC Filing Icon  
5/25/2023Caissa Capital Management Ltd.Major ShareholderBuy8$664.80$5,318.405,769View SEC Filing Icon  
5/22/2023Caissa Capital Management Ltd.Major ShareholderBuy29$801.60$23,246.405,723View SEC Filing Icon  
5/18/2023Caissa Capital Management Ltd.Major ShareholderBuy54$789.60$42,638.405,667View SEC Filing Icon  
5/15/2023Caissa Capital Management Ltd.Major ShareholderBuy7$612.00$4,284.005,611View SEC Filing Icon  
5/12/2023Caissa Capital Management Ltd.Major ShareholderBuy9$588.00$5,292.005,604View SEC Filing Icon  
5/8/2023Caissa Capital Management Ltd.Major ShareholderBuy20$628.80$12,576.005,594View SEC Filing Icon  
5/4/2023Caissa Capital Management Ltd.Major ShareholderBuy62$669.60$41,515.205,552View SEC Filing Icon  
4/26/2023Caissa Capital Management Ltd.Major ShareholderBuy1$712.80$712.805,484View SEC Filing Icon  
4/24/2023Caissa Capital Management Ltd.Major ShareholderBuy52$734.40$38,188.805,459View SEC Filing Icon  
4/20/2023Caissa Capital Management Ltd.Major ShareholderBuy20$739.20$14,784.005,407View SEC Filing Icon  
4/17/2023Caissa Capital Management Ltd.Major ShareholderBuy62$710.40$44,044.805,344View SEC Filing Icon  
4/10/2023Caissa Capital Management Ltd.Major ShareholderBuy130$547.20$71,136.005,177View SEC Filing Icon  
12/9/2022Garry Arthur NeilCEOBuy8$1,060.80$8,486.4038View SEC Filing Icon  
3/14/2022Armistice Capital, LlcDirectorBuy416$156.00$64,896.00View SEC Filing Icon  
3/10/2022Armistice Capital, LlcDirectorBuy108$168.00$18,144.00View SEC Filing Icon  
3/7/2022Armistice Capital, LlcDirectorBuy1,354$158.40$214,473.60View SEC Filing Icon  
3/3/2022Armistice Capital, LlcDirectorBuy208$170.40$35,443.20View SEC Filing Icon  
2/24/2022Armistice Capital, LlcDirectorBuy416$192.00$79,872.00View SEC Filing Icon  
2/22/2022Armistice Capital, LlcDirectorBuy345$184.80$63,756.00View SEC Filing Icon  
2/17/2022Armistice Capital, LlcDirectorBuy625$194.40$121,500.00View SEC Filing Icon  
1/20/2022Armistice Capital, LlcDirectorBuy50$204.00$10,200.00View SEC Filing Icon  
1/18/2022Armistice Capital, LlcDirectorBuy859$211.20$181,420.80View SEC Filing Icon  
1/14/2022Armistice Capital, LlcDirectorBuy354$223.20$79,012.80View SEC Filing Icon  
1/12/2022Armistice Capital, LlcDirectorBuy238$249.60$59,404.80View SEC Filing Icon  
1/10/2022Armistice Capital, LlcDirectorBuy2,046$237.60$486,129.60View SEC Filing Icon  
1/7/2022Armistice Capital, LlcDirectorBuy574$249.60$143,270.40View SEC Filing Icon  
12/10/2021Christopher Ryan SullivanCAOBuy3$376.80$1,130.40View SEC Filing Icon  
12/10/2021H. Jeffrey WilkinsInsiderBuy26$376.80$9,796.80View SEC Filing Icon  
12/10/2021Schond L. GreenwayCFOBuy9$376.80$3,391.20View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Avalo Therapeutics (NASDAQ:AVTX)

87.06% of Avalo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AVTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Avalo Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024Ikarian Capital LLC46,648$1.02M0.1%N/A4.511%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC10,000$0.22M0.0%N/A0.971%Search for SEC Filing on Google Icon
5/14/2024Natixis2,512$55K0.0%-45.4%0.244%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC283,306$34K0.0%N/A1.399%Search for SEC Filing on Google Icon
8/11/2023VR Adviser LLC1,250,000$0.44M0.1%+25.0%6.173%Search for SEC Filing on Google Icon
5/16/2023Great Point Partners LLC474,639$0.83M0.2%N/A3.595%Search for SEC Filing on Google Icon
5/5/2023Monashee Investment Management LLC60,000$0.11M0.0%N/A0.455%Search for SEC Filing on Google Icon
2/15/2023Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319%Search for SEC Filing on Google Icon
11/10/2022Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819%Search for SEC Filing on Google Icon
10/27/2022Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166%Search for SEC Filing on Google Icon
8/15/2022Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280%Search for SEC Filing on Google Icon
8/15/2022Opaleye Management Inc.450,000$0.23M0.1%-69.1%4.780%Search for SEC Filing on Google Icon
5/12/2022Integral Health Asset Management LLC700,000$0.51M0.1%-56.9%0.621%Search for SEC Filing on Google Icon
5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344%Search for SEC Filing on Google Icon
2/15/2022LGL Partners LLC28,850$49K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/14/2022Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/14/2022Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp533,578$0.91M0.0%+3.1%0.475%Search for SEC Filing on Google Icon
2/1/2022Assenagon Asset Management S.A.582,718$0.99M0.0%-33.7%0.519%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio38,400$65K0.0%-40.2%0.034%Search for SEC Filing on Google Icon
1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP197,133$0.43M0.0%N/A0.176%Search for SEC Filing on Google Icon
11/16/2021Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299%Search for SEC Filing on Google Icon
11/16/2021Squarepoint Ops LLC18,657$41K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP732,931$1.60M0.0%N/A0.653%Search for SEC Filing on Google Icon
11/16/2021Laurion Capital Management LP330,444$0.72M0.0%N/A0.294%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350%Search for SEC Filing on Google Icon
11/15/2021Atom Investors LP27,507$60K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/15/2021Voya Investment Management LLC21,854$48K0.0%N/A0.019%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP11,812$26K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/12/2021Aristides Capital LLC48,953$0.11M0.0%N/A0.044%Search for SEC Filing on Google Icon
11/12/2021Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126%Search for SEC Filing on Google Icon
11/12/2021Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610%Search for SEC Filing on Google Icon
11/10/2021Creative Planning14,814$32K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/10/2021Alliancebernstein L.P.19,100$42K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC270,000$0.59M0.1%N/A0.245%Search for SEC Filing on Google Icon
11/8/2021Meeder Asset Management Inc.19,260$43K0.0%N/A0.017%Search for SEC Filing on Google Icon
11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG31,794$69K0.0%N/A0.029%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund22,214$48K0.0%N/A0.020%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.15,788$34K0.0%N/A0.014%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC18,596$41K0.0%N/A0.017%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC52,000$0.11M0.0%N/A0.047%Search for SEC Filing on Google Icon
10/25/2021Minot Wealth Management LLC103,410$0.23M0.0%N/A0.094%Search for SEC Filing on Google Icon
10/22/2021Strs Ohio64,200$0.14M0.0%N/A0.058%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797%Search for SEC Filing on Google Icon
10/19/2021Tamar Securities LLC23,084$50K0.0%N/A0.021%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Avalo Therapeutics logo
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. The company's drug candidates include AVTX-009, an Anti-IL-1ß monoclonal antibody which is under Phase I targeting inflammatory diseases; and AVTX-008, a fully human B and T lymphocyte attenuator agonist fusion protein for the treatment of immune dysregulation disorders. It also develops Quisovalimab (AVTX-002), an Anti-LIGHT mAb which is in phase II for immune-inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.
Read More on Avalo Therapeutics

Today's Range

Now: $10.56
Low: $10.30
High: $11.39

50 Day Range

MA: $12.65
Low: $9.59
High: $17.12

52 Week Range

Now: $10.56
Low: $3.95
High: $1,130.40

Volume

11,610 shs

Average Volume

386,146 shs

Market Capitalization

$10.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.14

Who are the company insiders with the largest holdings of Avalo Therapeutics?

Avalo Therapeutics' top insider shareholders include:
  1. Armistice Capital, Llc (Major Shareholder)
  2. Caissa Capital Management Ltd (Major Shareholder)
  3. Garry Arthur Neil (CEO)
  4. Christopher Ryan Sullivan (CFO)
Learn More about top insider investors at Avalo Therapeutics.

Who are the major institutional investors of Avalo Therapeutics?

Avalo Therapeutics' top institutional shareholders include:
  1. Ikarian Capital LLC — 4.51%
  2. Affinity Asset Advisors LLC — 0.97%
  3. Natixis — 0.24%
  4. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Avalo Therapeutics stock.

Which major investors are selling Avalo Therapeutics stock?

During the previous quarter, AVTX stock was sold by these institutional investors:
  1. Natixis

Which major investors are buying Avalo Therapeutics stock?

Within the last quarter, AVTX stock was acquired by institutional investors including:
  1. Ikarian Capital LLC
  2. Affinity Asset Advisors LLC
During the previous year, these company insiders have bought Avalo Therapeutics stock:
  1. Armistice Capital, Llc (Major Shareholder)
  2. Caissa Capital Management Ltd (Major Shareholder)
  3. Garry Arthur Neil (CEO)
Learn More investors buying Avalo Therapeutics stock.